MCKESSON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 559.2 USD | +0.74% |
|
+5.50% | +20.52% |
| May. 09 | Deutsche Bank Adjusts Price Target on McKesson to $545 From $547 | MT |
| May. 09 | Wells Fargo Adjusts Price Target on McKesson to $551 From $502 | MT |
Presentation Operator MessageOperator (Operator)Welcome to McKesson's Q2 Fiscal 2022 Earnings ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
555.1
USD
Average target price
577.9
USD
Spread / Average Target
+4.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.52% | 72.16B | |
| -1.12% | 23.88B | |
| +8.25% | 8.35B | |
| +5.13% | 8.29B | |
| -19.42% | 8.18B | |
| +5.56% | 4.81B | |
| +16.83% | 4.4B | |
| -1.83% | 4B | |
| -1.51% | 3.92B | |
| +26.97% | 3.79B |
- Stock Market
- Equities
- MCK Stock
- News McKesson Corporation
- Transcript : McKesson Corporation, Q2 2022 Earnings Call, Nov 01, 2021